Navigation Links
Massachusetts General Hospital's Warren Triennial Prize to honor pioneers of cellular reprogramming
Date:12/16/2010

The 2011 Warren Triennial Prize of Massachusetts General Hospital (MGH) will be awarded to Shinya Yamanaka, MD, PhD, who discovered a method to convert adult cells into cells with characteristics of embryonic stem cells, and Rudolf Jaenisch, MD, whose extension of Yamanaka's work includes using those cells to generate animal models of important human diseases. The award will be presented at a daylong symposium in October 2011, part of the celebration of the 200th anniversary of the founding of the MGH. Yamanaka is director of the Center for iPS Cell Research and Application at Kyoto University in Japan and a senior investigator at the Gladstone Institutes in San Francisco. Jaenisch is a founding member of the Whitehead Institute for Biomedical Research and a professor of Biology at Massachusetts Institute of Technology (MIT).

"The Warren Triennial is the top scientific award presented by the MGH, and we are delighted to be able to honor the groundbreaking work of Drs. Yamanaka and Jaenisch," says Daniel Haber, MD, PhD, chair of the MGH Executive Committee on Research and director of the MGH Cancer Center. "Their research has opened up a new direction for the future of medicine, and the MGH is particularly proud to recognize these discoveries in our bicentennial year, in which we will celebrate both the rich history and future promise of biomedical research."

Awarded every third year, the Warren Prize honors scientists who have made outstanding contributions in fields related to medicine and includes a cash award of $50,000. Created in 1871, the prize was named for Dr. John Collins Warren, a co-founder of the MGH who played a leading role in establishing what became the New England Journal of Medicine and also performed the first public surgical operation utilizing ether anesthesia on October 16, 1846. Twenty-two Warren recipients have also received the Nobel Prize, most recently 2004 recipients Craig Mello, PhD, and Andrew Fire, PhD, w
'/>"/>

Contact: Sue McGreevey
smcgreevey@partners.org
617-724-2764
Massachusetts General Hospital
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. L-1 Identity Solutions Awarded New Massachusetts RMV Drivers License Contract Valued at an Estimated $32 Million
2. Journal of General Physiology explores mysteries of TRP channels in latest Perspectives series
3. American Society for Microbiology to host 109th general meeting in Philadelphia
4. General tumor marker test now offered by GenWay clinical laboratory
5. TWAS 11th General Conference
6. HFSP President Arima and Secretary General Winnacker awarded for fostering cooperation with China
7. Modern man found to be generally monogamous, moderately polygamous
8. American Society for Microbiology to host 110th general meeting in San Diego
9. Oil Refineries Announces Delay to Annual & Special General Meeting
10. Mass. General researchers develop functional, transplantable rat liver grafts
11. Major moral decisions use general-purpose brain circuits to manage uncertainty
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... MOUNTAIN VIEW, Calif. , Dec. 18, 2014 /PRNewswire/ ... the publication of a study that pinpoints fine-scale differences ... the United States . Since immigrants ... the United States has served as ... study illuminates how American history and the ongoing mixing ...
(Date:12/17/2014)... Dec. 15, 2014 The Defense Logistics ... easier to detect and prevent counterfeit microcircuits from ... the agency started performing an in-house microcircuit anti-counterfeit ... the authenticity of purchased microcircuits while increasing their ... control measures will be conducted at DLA,s Electronics ...
(Date:12/17/2014)... , Dec. 16, 2014 Research and ... the addition of the "Global Chemical Sensor ... http://photos.prnewswire.com/prnh/20130307/600769 ... the increasing demand for medical sensors in biomedical ... data for quick and correct diagnosis during surgical ...
Breaking Biology News(10 mins):23andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2
... species within a community and are commonly transmitted ... pathogen emergence and therefore has been considered as ... of agricultural importance. Many pathogens like malaria, Lyme ... hosts are commonly transmitted by vectors, and their ...
... Researchers at Yale, in collaboration with NIH researchers, have ... the immune system for detection of parasitic infections, leading ... these infections. , Published in the April 28 issue ... how infectious parasites interface with the immune system--a problem ...
... shows that farmers who used agricultural insecticides experienced ... longer using the products. Data from 18,782 North ... including organophosphates and organochlorines, to reports of reoccurring ... and other neurological symptoms. Some of the insecticides ...
Cached Biology News:A new study examines how shared pathogens affect host populations 2Yale researchers identify molecule for detecting parasitic infection in humans 2Use of Insecticides Linked to Lasting Neurological Problems for Farmers 2
(Date:12/24/2014)... LONDON , December 23, 2014 ... Review Algeria , out today and available for free ... the actors driving change and growth in the sector today. ... has scored notable successes has been in developing a homegrown ... 70 percent local production still remains some way off. A ...
(Date:12/22/2014)... The Center for Professional Innovation ... training across the life sciences industry, has partnered with ... to provide the organization's members with discounted classroom courses, ... the more than 350 sessions across 80 course titles. ... when registering for a public course at ...
(Date:12/22/2014)... DIEGO , Dec. 22, 2014 GenomeDx ... the Decipher Prostate Cancer Classifier, a genomic test for ... in node-negative, high-risk men managed by radical prostatectomy without ... radical prostatectomy is relatively uncommon, using tumor genomics to ... of metastatic disease is an important advance. The study ...
(Date:12/22/2014)... Memphis, TENN (PRWEB) December 22, 2014 ... with Donor Egg Bank USA , a network ... the country. Through this partnership, patients have fast access ... for in vitro fertilization, IVF . Fertility Associates of ... to offer this fertility treatment option. , Dr. ...
Breaking Biology Technology:PharmaBoardroom Releases New Algeria Pharmaceuticals Report 2PharmaBoardroom Releases New Algeria Pharmaceuticals Report 3CfPIE Announces Partnership with the Society for Clinical Data Management 2CfPIE Announces Partnership with the Society for Clinical Data Management 3Study Published in European Urology Shows that the Decipher Prostate Cancer Classifier is Predictive of Rapid Metastasis in High-Risk Men who have had Prostate Surgery 2Study Published in European Urology Shows that the Decipher Prostate Cancer Classifier is Predictive of Rapid Metastasis in High-Risk Men who have had Prostate Surgery 3Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 3
... June 21 /PRNewswire-FirstCall/ - Aeterna Zentaris Inc. (NASDAQ: ... drug development company specialized in oncology and endocrinology, announced ... direct offering of US$12.1 million of units ... to certain institutional investors. Net proceeds from this offering, ...
... Fla. , June 21 Dyadic International, ... cutting-edge C1 platform technology addresses the needs of the ... scale which efficiently convert biomass into ethanol and other ... engaged the influential consulting firm, The Abraham Group, to ...
... WA , and VANCOUVER , June 21 ... ) announced today the initiation of a Phase 3 ... candidate being developed for the treatment of castrate-resistant prostate ... Cancer SATURN Trial, is the first of three Phase ...
Cached Biology Technology:Aeterna Zentaris Receives US$12 Million on Closing of Registered Direct Offering 2Aeterna Zentaris Receives US$12 Million on Closing of Registered Direct Offering 3Dyadic International Engages The Abraham Group as Strategic Advisor 2Dyadic International Engages The Abraham Group as Strategic Advisor 3Dyadic International Engages The Abraham Group as Strategic Advisor 4OncoGenex Pharmaceuticals Announces Initiation of a Phase 3 Trial in Men with Metastatic Prostate Cancer 2OncoGenex Pharmaceuticals Announces Initiation of a Phase 3 Trial in Men with Metastatic Prostate Cancer 3OncoGenex Pharmaceuticals Announces Initiation of a Phase 3 Trial in Men with Metastatic Prostate Cancer 4OncoGenex Pharmaceuticals Announces Initiation of a Phase 3 Trial in Men with Metastatic Prostate Cancer 5
Values of steady state parameters for enzyme activities are determined....
... (PPAR) is a member of a ... factors that heterodimerize with retinoic acid-like ... the regulation of glucose and lipid ... of anti-diabetic agents called thiazolidinediones (TZD) ...
... This protein identification Service includes 1. ... protein spots 3. High-sensitive tryptic in-gel ... of samples for MALDI-MS 5. Acquisition ... via MALDI-MS (Bruker ultraflex TOF/TOF) 6. ...
... Preparation Reconstitution: one vial contains ... ficoll and 50 mg PVP; ... water yields a 50concentrate Special ... 1.00 g/mL (20 C) Quality ...
Biology Products: